TB-500 alternatives.

5 compounds compared to TB-500, ranked by published evidence tier and regulatory status, not by what's marketed hardest.

Why people look for an alternative

The first thing to know about TB-500 alternatives is that TB-500 is not a settled thing to be an alternative to. It is marketed as thymosin beta-4, but many products labeled TB-500 are a shorter synthetic fragment built around the actin-binding motif rather than the full 43-amino-acid peptide, so the identity of a given vial is often unverified. That uncertainty is itself a common reason to look elsewhere. The others are its WADA prohibition at all times under class S2 and its lack of approval anywhere. Full-length thymosin beta-4 is the more defined molecule, but it remains investigational, so this is a swap for clarity rather than for evidence.

What you're comparing against
TB-500
F tier · 30/100Research / preclinical

TB-500 is a synthetic peptide sold for research use and widely marketed as "thymosin beta-4 (Tβ4)." Naturally occurring Tβ4 is a 43-amino-acid, ~4.9 kDa actin-sequestering peptide found in nearly all mammalian cells and at high concentration in platelets and wound fluid.

Ranked by evidence · strongest first
  1. 01
    Thymosin β-4
    D tierResearch / preclinical

    Acts through the angiogenesis and tissue repair pathway, like TB-500. Research / preclinical.

  2. 02
    BPC-157
    D tierResearch / preclinical
    body protection compound

    Acts through the angiogenesis and tissue repair pathway, like TB-500. Research / preclinical.

  3. 03
    Pentosan Polysulfate
    B tierFDA-approved
    Elmiron

    Same category: healing & recovery. FDA-approved.

  4. 04
    Larazotide
    C tierIn human trials
    AT-1001 · larazotide acetate

    Same category: healing & recovery. In human trials.

  5. 05
    B7-33
    F tierResearch / preclinical
    single-chain relaxin analog

    Same category: healing & recovery. Research / preclinical.

How this list is built

An “alternative” here means a compound that shares TB-500's mechanism pathway or sits in the same category, not a marketing substitute. Each is ordered by PepCue's evidence tier (a weighted 0–100 score across human data, safety, replication and regulatory clarity), then by whether it's actually approved. This is a research reference, not medical or purchasing advice: an alternative sitting higher on evidence does not mean it's right, safe, or legal for any given use. Reviewed June 1, 2026.

Comparing options with your provider?

PepCue keeps every compound, dose and lab in one private, provider-ready timeline, whichever one you land on.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page
Compounds